These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15937448)

  • 21. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls.
    Han SH; Hulette C; Saunders AM; Einstein G; Pericak-Vance M; Strittmatter WJ; Roses AD; Schmechel DE
    Exp Neurol; 1994 Jul; 128(1):13-26. PubMed ID: 8070517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Proteins of Alzheimer's disease].
    Piekiełko A
    Postepy Biochem; 1999; 45(2):116-22. PubMed ID: 10581635
    [No Abstract]   [Full Text] [Related]  

  • 23. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
    van de Nes JA; Nafe R; Schlote W
    Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogenesis of Alzheimer's disease and dementia.
    Bugiani O
    Rev Neurol (Paris); 1999; 155 Suppl 4():S28-32. PubMed ID: 10637935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytoskeletal pathologies of Alzheimer disease.
    Bamburg JR; Bloom GS
    Cell Motil Cytoskeleton; 2009 Aug; 66(8):635-49. PubMed ID: 19479823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alzheimer's disease: beta-Amyloid protein and tau.
    Morishima-Kawashima M; Ihara Y
    J Neurosci Res; 2002 Nov; 70(3):392-401. PubMed ID: 12391602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Tau, amyloid and Alzheimer's disease].
    Olesen OF
    Ugeskr Laeger; 1994 Feb; 156(8):1116-7, 1121-4. PubMed ID: 8116089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Active caspase-6 and caspase-6-cleaved tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer's disease.
    Guo H; Albrecht S; Bourdeau M; Petzke T; Bergeron C; LeBlanc AC
    Am J Pathol; 2004 Aug; 165(2):523-31. PubMed ID: 15277226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell biology of the beta-amyloid precursor protein and the genetics of Alzheimer's disease.
    Selkoe DJ
    Cold Spring Harb Symp Quant Biol; 1996; 61():587-96. PubMed ID: 9246485
    [No Abstract]   [Full Text] [Related]  

  • 30. Neuropathological characterization of mutant amyloid precursor protein yeast artificial chromosome transgenic mice.
    Kulnane LS; Lamb BT
    Neurobiol Dis; 2001 Dec; 8(6):982-92. PubMed ID: 11741394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coenzyme q induces tau aggregation, tau filaments, and Hirano bodies.
    Santa-Mara I; Santpere G; MacDonald MJ; Gomez de Barreda E; Hernandez F; Moreno FJ; Ferrer I; Avila J
    J Neuropathol Exp Neurol; 2008 May; 67(5):428-34. PubMed ID: 18431254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trafficking of Alzheimer's disease-related membrane proteins and its participation in disease pathogenesis.
    Suzuki T; Araki Y; Yamamoto T; Nakaya T
    J Biochem; 2006 Jun; 139(6):949-55. PubMed ID: 16788045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aberrant accentuation of neurofibrillary degeneration in the hippocampus of Alzheimer's disease with amyloid precursor protein 717 and presenilin-1 gene mutations.
    Sudo S; Shiozawa M; Cairns NJ; Wada Y
    J Neurol Sci; 2005 Jul; 234(1-2):55-65. PubMed ID: 15946688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Markers of apoptosis and models of programmed cell death in Alzheimer's disease.
    Hugon J; Terro F; Esclaire F; Yardin C
    J Neural Transm Suppl; 2000; 59():125-31. PubMed ID: 10961425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amyloid precursor protein cytoplasmic domain with phospho-Thr668 accumulates in Alzheimer's disease and its transgenic models: a role to mediate interaction of Abeta and tau.
    Shin RW; Ogino K; Shimabuku A; Taki T; Nakashima H; Ishihara T; Kitamoto T
    Acta Neuropathol; 2007 Jun; 113(6):627-36. PubMed ID: 17431643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein E interaction with the neurofibrillary tangles and senile plaques in Alzheimer disease: implications for disease pathogenesis.
    Richey PL; Siedlak SL; Smith MA; Perry G
    Biochem Biophys Res Commun; 1995 Mar; 208(2):657-63. PubMed ID: 7695621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Alzheimer's disease: lesions and their progression].
    Duyckaerts C; Colle MA; Delatour B; Hauw JJ
    Rev Neurol (Paris); 1999; 155 Suppl 4():S17-27. PubMed ID: 10637934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hirano bodies contain tau protein.
    Galloway PG; Perry G; Kosik KS; Gambetti P
    Brain Res; 1987 Feb; 403(2):337-40. PubMed ID: 3103867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Model Hirano bodies protect against tau-independent and tau-dependent cell death initiated by the amyloid precursor protein intracellular domain.
    Furgerson M; Fechheimer M; Furukawa R
    PLoS One; 2012; 7(9):e44996. PubMed ID: 23028730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alzheimer's disease-like neuropathology of gene-targeted APP-SLxPS1mut mice expressing the amyloid precursor protein at endogenous levels.
    Köhler C; Ebert U; Baumann K; Schröder H
    Neurobiol Dis; 2005 Nov; 20(2):528-40. PubMed ID: 15921918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.